Skip to main content
MedPathMedPath Home
Clinical Trials/NCT01438892
NCT01438892
Completed
Not Applicable

Impact Of RA Therapy Compliance On Patient-Reported Outcomes

Pfizer0 sites396 target enrollmentFebruary 2012
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsRheumatoid Arthritis
InterventionstDMARDsbiodmards
DrugstDMARDsbiodmards

Overview

Phase
Not Applicable
Intervention
tDMARDs
Conditions
Rheumatoid Arthritis
Sponsor
Pfizer
Enrollment
396
Primary Endpoint
HAQ
Status
Completed
Last Updated
13 years ago
OverviewInvestigatorsEligibility CriteriaArms & InterventionsOutcomesSimilar Trials

Overview

Brief Summary

Several observational studies have evaluated the comparative treatment costs associated with each agent, particularly those within the anti-TNF class, but few have evaluated the impact of therapy compliance, persistence, treatment patterns on patient reported outcomes, healthcare utilization and costs, using a provider database. This study is designed to fill in this information gap.

Detailed Description

Cohort observational

Registry
clinicaltrials.gov
Start Date
February 2012
End Date
January 2013
Last Updated
13 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Pfizer
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •Adults with moderate to severe RA who are currently using a DMARD

Exclusion Criteria

  • •Psoriatic Arthritis (PsA), Psoriasis (PsO), SSystemic Lupus Erythematosus (SLE), Non-Disease modifying anti-rheumatic disease (non-DMARD) use

Arms & Interventions

tDMARDs Group

traditional DMARDs

Intervention: tDMARDs

Biologics group

Biologics used in RA

Intervention: biodmards

Outcomes

Primary Outcomes

HAQ

Time Frame: 12 months

36-Item Short-Form Health Survey (SF-36)

Time Frame: 12 months

Secondary Outcomes

  • Compliance(12 months)

Similar Trials

Completed
Not Applicable
Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs BiologicsArthritis, Rheumatoid
NCT03964649Pfizer7,308
Not yet recruiting
Not Applicable
‘Comparison of costs and patient reported outcomes of endovenous techniques in the treatment of incompetent saphenous veins;’A single center, double blinded, randomized controlled trial.varicose veins, endovenous treatment, VNUS, endolaser
NL-OMON22362no sponsor70
Completed
Not Applicable
Health Outcomes in Rheumatoid ArthritisRheumatoid Arthritis
NCT00346411Johns Hopkins University164
Not yet recruiting
Not Applicable
Measuring the therapy-effect of a mandibular repositioning appliance (MRA): A new method.mild-to-moderate Obstructive Sleep Apnea Syndrome (OSAS)
NL-OMON26447Medical Spectrum Twente, Enschede15
Completed
Phase 4
A Study on Antiretroviral Therapy (ART) Naïve Patients On Different Regimens to Treat Hiv (NORTHIV)HIV
NCT01445223Göteborg University242